VBI Vaccines Inc.

NASDAQ:VBIV   3:59:51 PM EDT
0.81
-0.02 (-2.52%)
Products

VBI Vaccines Receives U.S. FDA Orphan Drug Designation For Vbi-1901 For The Treatment Of Glioblastoma

Published: 06/22/2022 12:34 GMT
VBI Vaccines Inc. (VBIV) - Vbi Vaccines Receives U.S. FDA Orphan Drug Designation for Vbi-1901 for the Treatment of Glioblastoma.